Chiffres calculés à partir des déclarations réglementaires officielles — .
| Initié | Type | Valeur · USD | Détail | |
|---|---|---|---|---|
| REDMILE BIOPHARMA INVESTMENTS III | Attribution | $6.3M | AMF | |
| Sofinnova Partners SAS |
| Attribution |
| $3.6M |
| AMF |
| REDMILE BIOPHARMA INVESTMENTS III | Attribution | $1.9M | AMF |
| Sofinnova Partners SAS | Attribution | $1.1M | AMF |
| REDMILE BIOPHARMA INVESTMENTS III | Attribution | $10.3M | AMF |
| Sofinnova Partners SAS | Attribution | $7.5M | AMF |
| INVUS | Vente | $30.7M | AMF |
| REDMILE BIOPHARMA INVESTMENTS III | AttributionD (dérivé) | $3.5M | AMF |
| REDMILE BIOPHARMA INVESTMENTS III | Attribution | $14.2M | AMF |
| Sofinnova Partners SAS | Attribution | $7.7M | AMF |
| Sofinnova Partners SAS | Attribution | $2.7M | AMF |
| Sofinnova Partners SAS | Attribution | $7.2M | AMF |
| Sofinnova Partners SAS | AttributionD (dérivé) | $8.5M | AMF |
| Sofinnova Partners SAS | AutreD (dérivé) | $8.2M | AMF |